FPH.AX · FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Australia · RS rating 94 · As of 2026-10-14
| Price | 39.02 AUD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 94 / 91 / 83 / 84 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 45 / 51 / 43 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +0.4% |
| Market cap (USD) | $15.7B |